Cited by 3,114T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Molecular mechanisms of T cell co-stimulation and co-inhibition

Open access

Chen, Lieping, Flies, Dallas B.·2013·Nature Reviews Immunology

Open this paper in CoChat — free account

Abstract

Co-stimulatory and co-inhibitory receptors have a pivotal role in T cell biology, as they determine the functional outcome of T cell receptor (TCR) signalling. The classic definition of T cell co-stimulation continues to evolve through the identification of new co-stimulatory and co-inhibitory receptors, the biochemical characterization of their downstream signalling events and the delineation of their immunological functions. Notably, it has been recently appreciated that co-stimulatory and co-inhibitory receptors display great diversity in expression, structure and function, and that their functions are largely context dependent. Here, we focus on some of these emerging concepts and review the mechanisms through which T cell activation, differentiation and function is controlled by co-stimulatory and co-inhibitory receptors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nri3405

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Self-citation
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
T cell exhaustion
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
The B7 family revisited
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,072
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860

Flagged first, then by citations

Show all 135 references

Research works printed but not linked: 1

Lafferty, K. J. & Cunningham, A. J. A. New analysis of allogeneic interactions. J. Immunol. 112, 436–437 (1975). Lafferty and Cunningham extended the Bretscher and Cohn two-signal model to suggest that T cells require two signals for activation.

Sorted by citations

Items 501–600 of 1,003

Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy
Isser, A., Livingston, N. K., & Schneck, J. P. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120584 · Cited by 77
OX40- and CD27-Mediated Costimulation Synergizes with Anti–PD-L1 Blockade by Forcing Exhausted CD8+ T Cells To Exit Quiescence
Buchan, S. L., Manzo, T., Flutter, B. R., Rogel, A., Edwards, N., Zhang, L., Sivakumaran, S., Ghorashian, S., Carpenter, B., Bennett, C. L., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401644 · Cited by 79
Exploring immune checkpoints as potential therapeutic targets in atherosclerosis
Kusters, P. J. H., Lutgens, E., & Seijkens, T. T. P. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx248 · Cited by 81
Intestinal Barrier Interactions with Specialized CD8 T Cells
Konjar, Š., Ferreira, C., Blankenhaus, B., & Veldhoen, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01281 · Cited by 77
Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review)
Yu, Y., & Cui, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9219 · Cited by 80
Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function
Poznanski, S. M., Barra, N. G., Ashkar, A. A., & Schertzer, J. D. (2018) · Inflammation Research · doi:10.1007/s00011-018-1174-3 · Cited by 78
Genetic influences on susceptibility to rheumatoid arthritis in African-Americans
Laufer, V. A., Tiwari, H. K., Reynolds, R. J., Danila, M. I., Wang, J., Edberg, J. C., Kimberly, R. P., Kottyan, L. C., Harley, J. B., Mikuls, T. R., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy395 · Cited by 83
Tislelizumab uniquely binds to the CC′ loop of PD‐1 with slow‐dissociated rate and complete PD‐L1 blockage
Hong, Y., Feng, Y., Sun, H., Zhang, B., Wu, H., Zhu, Q., Li, Y., Zhang, T., Zhang, Y., Cui, X., et al. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13102 · Cited by 81
Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy
Wang, K., Zhang, X., Ye, H., Wang, X., Fan, Z., Lu, Q., Li, S., Zhao, J., Zheng, S., He, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42155-z · Cited by 78
“2i) 36,37 .”
Mechanistic Assessment of PD-1H Coinhibitory Receptor–Induced T Cell Tolerance to Allogeneic Antigens
Flies, D. B., Higuchi, T., & Chen, L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402648 · Cited by 78
Self-citation
Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
Jeong, S., & Park, S. (2020) · Immune Network · doi:10.4110/in.2020.20.e3 · Cited by 78
Targeting MHC-I inhibitory pathways for cancer immunotherapy
Wang, J., Qiao, L., Chen, X., & Aifantis, I. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.01.009 · Cited by 82
IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer
Xu, L., Peng, F., Luo, Q., Ding, Y., Yuan, F., Zheng, L., He, W., Zhang, S. S., Fu, X., Liu, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.032 · Cited by 89
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu
Kunert, A., Straetemans, T., Govers, C., Lamers, C., Mathijssen, R. H. J., Sleijfer, S., & Debets, R. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00363 · Cited by 77
Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus
Sullivan, B. A., Tsuji, W. H., Kivitz, A., Peng, J. Z., Arnold, G. E., Boedigheimer, M. J., Chiu, K., Green, C. L., Kaliyaperumal, A., Wang, C., et al. (2016) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000146 · Cited by 76
Expression of PD-1 on CD4+ T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer
Zheng, H., Liu, X., Zhang, J., Rice, S. J., Wagman, M., Kong, Y., Zhu, L., Zhu, J., Joshi, M., & Belani, C. P. (2016) · Oncotarget · doi:10.18632/oncotarget.9316 · Cited by 76
T-cell calcium dynamics visualized in a ratiometric tdTomato-GCaMP6f transgenic reporter mouse
Dong, H., Othy, S., Jairaman, A., Skupsky, J., Zavala, A., Parker, I., Dynes, J. L., & Cahalan, M. D. (2017) · eLife · doi:10.7554/elife.32417 · Cited by 76
Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling
Gilson, R. C., Gunasinghe, S. D., Johannes, L., & Gaus, K. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.101010 · Cited by 74
Extracellular Vesicles and Tumor-Immune Escape: Biological Functions and Clinical Perspectives
Raimondo, S., Pucci, M., Alessandro, R., & Fontana, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072286 · Cited by 79
Superfast desulfurization for protein chemical synthesis and modification
Sun, Z., Ma, W., Cao, Y., Wei, T., Mo, X., Chow, H. Y., Tan, Y., Cheung, C. H. P., Liu, J., Lee, H. K., et al. (2022) · Chem · doi:10.1016/j.chempr.2022.07.017 · Cited by 76
Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis
Guptill, J. T., Soni, M., & Meriggioli, M. N. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0398-y · Cited by 78
A three‐signal model of T ‐cell lymphoma pathogenesis
Wilcox, R. A. (2015) · American Journal of Hematology · doi:10.1002/ajh.24203 · Cited by 77
Structural characterization of a pectic polysaccharide from Codonopsis pilosula and its immunomodulatory activities in vivo and in vitro
Zhang, P., Hu, L., Bai, R., Zheng, X., Ma, Y., Gao, X., Sun, B., & Hu, F. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.06.023 · Cited by 76
GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg
Xu, K., Yang, W. Y., Nanayakkara, G., Shao, Y., Yang, F., Hu, W., Choi, E. T., Wang, H., & Yang, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00045 · Cited by 78
Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
Menter, T., & Tzankov, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00054 · Cited by 77
IL-27 and TCR Stimulation Promote T Cell Expression of Multiple Inhibitory Receptors
DeLong, J. H., Hall, A. O., Rausch, M., Moodley, D., Perry, J. A., Park, J., Phan, A. T., Beiting, D. P., Kedl, R. M., Hill, J. A., et al. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1800083 · Cited by 74
Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
Lodewijk, I., Nunes, S. P., Henrique, R., Jerónimo, C., Dueñas, M., & Paramio, J. M. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01046-0 · Cited by 75
Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
Flies, D. B., Langermann, S., Jensen, C., Karsdal, M. A., & Willumsen, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199513 · Cited by 79
“A primarymechanism of T cell suppression is through interaction of T cell surface inhibitory receptors with inhibitory ligands expressed on the cell surface of tumor cells, tumor associated macrophages (TAMs) and DCs (TADCs), myeloid-derived suppressor cells (MDSCs) or other suppressive cell types in the TME (63).”
BackgroundSelf-citation
Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression
Wang, Y., Liu, B., Min, Q., Yang, X., Yan, S., Ma, Y., Li, S., Fan, J., Wang, Y., Dong, B., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00591-7 · Cited by 82
“TNFRSF14 , expressed by Tregs and antigen-presenting cells (APCs), delivered inhibitory signals by interacting with co-inhibitory factor BTLA (B and T lymphocyte attenuator) or CD160 (upregulated in effector T cells 50 ).”
T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330
Laszlo, G. S., Gudgeon, C. J., Harrington, K. H., & Walter, R. B. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.68 · Cited by 78
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
Irving, M. B., de Silly, R. V., Scholten, K. B. J., Dilek, N., & Coukos, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00267 · Cited by 76
Clinical Development of Immune Checkpoint Inhibitors
Ito, A., Kondo, S., Tada, K., & Kitano, S. (2015) · BioMed Research International · doi:10.1155/2015/605478 · Cited by 79
TCR-engineered T cells to treat tumors: Seeing but not touching?
Debets, R., Donnadieu, E., Chouaı̈b, S., & Coukos, G. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.002 · Cited by 73
A cellular platform for the evaluation of immune checkpoint molecules
Jutz, S., Hennig, A., Paster, W., Asrak, Ö., Dijanovic, D., Kellner, F., Pickl, W. F., Huppa, J. B., Leitner, J. M., & Steinberger, P. (2017) · Oncotarget · doi:10.18632/oncotarget.17615 · Cited by 79
Oncolytic Viral Therapy Using Reovirus
Thirukkumaran, C. M., & Morris, D. G. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2727-2_12 · Cited by 75
Immune mechanisms mediating abscopal effects in radioimmunotherapy
Rodriguez-Ruiz, M. E., Rodríguez, I., Leaman, O., López‐Campos, F., Montero, A., Conde-Moreno, A. J., Aristu, J., Lara, P. C., Calvo, F. Á., & Melero, I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.12.002 · Cited by 76
Toxoplasma gondii: CD8 T Cells Cry for CD4 Help
Khan, I. A., Hwang, S., & Moretto, M. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00136 · Cited by 80
Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma
Song, M.-K., Park, B.-B., & Uhm, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061326 · Cited by 75
B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling
Rieder, S. A., Wang, J., White, N. M., Qadri, A. N., Ménard, C., Stephens, G. L., Karnell, J. L., Rudd, C. E., & Kolbeck, R. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0361-7 · Cited by 73
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation
Rovatti, P. E., Gambacorta, V., Lorentino, F., Ciceri, F., & Vago, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00147 · Cited by 74
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Kim, T. W., Burris, H. A., Miguel, M. J. D., Pishvaian, M. J., Bang, Y., Gordon, M. S., Awada, A. H., Camidge, D. R., Hodi, F. S., McArthur, G. A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4020 · Cited by 73
“Arthralgia 8 (15) 0 17 (16) 1 (1) 0 0 1 (25) 0 26 (15) 1 (1)”
BackgroundInfluential
Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines
Oladejo, M., Paulishak, W., & Wood, L. M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.003 · Cited by 75
Regulatory T cells and minimal change nephropathy: in the midst of a complex network
Bertelli, R., Bonanni, A., Donato, A. D., Cioni, M., Ravani, P., & Ghiggeri, G. M. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12675 · Cited by 76
Metabolic Consequences of T-cell Costimulation in Anticancer Immunity
Teijeira, Á., Garasa, S., Etxeberría, I., Gato, M., Melero, I., & Delgoffe, G. M. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0115 · Cited by 73
PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells
Stecher, C., Battin, C., Leitner, J. M., Zettl, M., Grabmeier‐Pfistershammer, K., Höeller, C., Zlabinger, G. J., & Steinberger, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00572 · Cited by 73
Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
Liu, D., Che, X., Wang, X., Ma, C., & Wu, G. (2023) · Pharmaceuticals · doi:10.3390/ph16101384 · Cited by 84
“[81,82].”
Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity
Northrup, L., Christopher, M. A., Sullivan, B. P., & Berkland, C. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.020 · Cited by 73
Lymphocytes and autoimmunity after spinal cord injury
Jones, T. B. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.003 · Cited by 76
Immunotherapy in Gastrointestinal Cancers
Procaccio, L., Schirripa, M., Fassan, M., Vecchione, L., Bergamo, F., Prete, A. A., Intini, R., Manai, C., Dadduzio, V., Boscolo, A., et al. (2017) · BioMed Research International · doi:10.1155/2017/4346576 · Cited by 72
Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians
Outh-Gauer, S., Alt, M., Tourneau, C. L., Augustin, J., Broudin, C., Gasne, C., Denize, T., Mirghani, H., Fabre, E., Ménard, M., et al. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.02.008 · Cited by 73
CTLA4 blockade promotes vessel normalization in breast tumors via the accumulation of eosinophils
Zheng, X., Zhang, N., Qian, L., Wang, X., Fan, P., Kuai, J., Lin, S., Liu, C., Jiang, W., Qin, S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32829 · Cited by 76
Checkpoint immunotherapy by nivolumab for treatment of metastatic melanoma
Koppolu, V., & Vasigala, V. R. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1290_16 · Cited by 74
Immune checkpoint inhibitors: new strategies to checkmate cancer
Wilson, R., Evans, T. R. J., Fraser, A. R., & Nibbs, R. J. B. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13081 · Cited by 72
Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies
Zhou, T., Su, T. T., Mudianto, T., & Wang, J. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200674 · Cited by 74
The PD-1:PD-L1 axis in Inflammatory Arthritis
Canavan, M., Floudas, A., Veale, D. J., & Fearon, U. (2021) · BMC Rheumatology · doi:10.1186/s41927-020-00171-2 · Cited by 73
Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design
Clemente, B., Denis, M., Silveira, C. P., Schiavetti, F., Brazzoli, M., & Stranges, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1294929 · Cited by 71
“Signal 3 encompasses the secretion of cytokines like IL-12 and type I IFNs, as well as the expression of surface molecules like CD70 and OX40L that regulate the proliferation, differentiation, and survival of primed T cells (22, 23).”
Background
Systemic lupus erythematosus: pathogenesis and targeted therapy
Su, X., Yu, H. M., Lei, Q., Chen, X., Tong, Y., Zhang, Z., Yang, W., Guo, Y., & Lin, L. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00217-8 · Cited by 84
“Co-stimulation of lymphocytes is a pivotal aspect of immunology, critical for regulating inflammation and guiding immunotherapeutic strategies [216–219].”
Allergic sensitization: host‐immune factors
van Ree, R., Hummelshøj, L., Plantinga, M., Poulsen, L. K., & Swindle, E. J. (2014) · Clinical and Translational Allergy · doi:10.1186/2045-7022-4-12 · Cited by 75
Immune checkpoint receptors: homeostatic regulators of immunity
Riva, A., & Chokshi, S. (2018) · Hepatology International · doi:10.1007/s12072-018-9867-9 · Cited by 71
Single‐Cell RNA‐Seq of T Cells in B‐ALL Patients Reveals an Exhausted Subset with Remarkable Heterogeneity
Wang, X., Chen, Y., Li, Z., Huang, B., Xu, L., Lai, J., Lu, Y., Zha, X., Liu, B., Lan, Y., et al. (2021) · Advanced Science · doi:10.1002/advs.202101447 · Cited by 71
Sialic Acid Ligands of CD28 Suppress Costimulation of T Cells
Edgar, L. J., Thompson, A. J., Vartabedian, V. F., Kikuchi, C., Woehl, J. L., Teijaro, J. R., & Paulson, J. C. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00525 · Cited by 68
Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
Zhang, T., Lin, Y., & Gao, Q. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0002 · Cited by 70
Role of cellular events in the pathophysiology of sepsis
Bhan, C., Dipankar, P., Chakraborty, P., & Sarangi, P. P. (2016) · Inflammation Research · doi:10.1007/s00011-016-0970-x · Cited by 68
Early T cell receptor signals globally modulate ligand:receptor affinities during antigen discrimination
Pielak, R. M., O’Donoghue, G. P., Lin, J. J., Alfieri, K. N., Fay, N. C., Low-Nam, S. T., & Groves, J. T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613140114 · Cited by 69
Expanding role of T cells in acute kidney injury
Kinsey, G. R., & Okusa, M. D. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000436695.29173.de · Cited by 68
4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39 + CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
Leem, G., Park, J., Jeon, M., Kim, E.-S., Kim, S. W., Lee, Y. J., Choi, S. J., Choi, B., Park, S., Jung, I., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001650 · Cited by 68
Emerging roles of astrocytes as immune effectors in the central nervous system
Fisher, T. M., & Liddelow, S. A. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.008 · Cited by 73
The role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma
Wang, S., Li, H., Li, B., Xie, T., Zhu, T., Sun, L., Ren, H., & Ye, Z. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.05.016 · Cited by 67
Co-Signaling Molecules in Maternal–Fetal Immunity
Xu, Y., Wang, S., Li, D., & Du, M. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.11.001 · Cited by 69
Small molecules targeting protein–protein interactions for cancer therapy
Wu, D., Li, Y., Zheng, L., Xiao, H., Ouyang, L., Wang, G., & Sun, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.035 · Cited by 71
“…molecules can be divided into two categories: the immunoglobulin superfamily (IGSF) and the tumour necrosis factor receptor family (TNFRF), of which the CD40 ‒ CD40L interaction was the ﬁrst TNFRSF costimulatory molecule identiﬁed and which is one of the most extensively studied TNFRSFs 82,83 .”
Background
Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung
Zhou, A. C., Wagar, L. E., Wortzman, M. E., & Watts, T. H. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.124 · Cited by 67
Dynamic Post-Transcriptional Events Governing CD8+ T Cell Homeostasis and Effector Function
Salerno, F., Turner, M., & Wolkers, M. C. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.01.001 · Cited by 59
The CD112R/CD112 axis: a breakthrough in cancer immunotherapy
Zeng, T., Cao, Y., Jin, T., Tian, Y., Dai, C., & Xu, F. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02053-y · Cited by 72
Invited review: From heat stress to disease—Immune response and candidate genes involved in cattle thermotolerance
Lemal, P., May, K., König, S., Schroyen, M., & Gengler, N. (2023) · Journal of Dairy Science · doi:10.3168/jds.2022-22727 · Cited by 75
Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment
Xia, X., He, C., Xue, Z., Wang, Y., Qin, Y., Ren, Z., Huang, Y., Luo, H., Chen, H., Zhang, W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57361-0 · Cited by 73
“Interestingly, the classic exhaustion-related genes were highly enriched in CXCL13 + CD4 + T cells, such as HAVCR2 , TIGIT , LAG3 , and PDCD1 51,52 (Fig.”
Memory T cells in organ transplantation: progress and challenges
Espinosa, J. R., Samy, K. P., & Kirk, A. D. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.9 · Cited by 71
Lysophospholipid Receptors, as Novel Conditional Danger Receptors and Homeostatic Receptors Modulate Inflammation—Novel Paradigm and Therapeutic Potential
Wang, X., Li, Y., Nanayakkara, G., Shao, Y., Liang, B., Cole, L. E., Yang, W. Y., Li, X., Cueto, R., Yu, J., et al. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9700-6 · Cited by 65
Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome
Braud, V. M., Biton, J., Becht, É., Knockaert, S., Mansuet‐Lupo, A., Cosson, E., Damotte, D., Alifano, M., Validire, P., Anjuère, F., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1423184 · Cited by 69
T Cell Co-stimulation and Functional Modulation by Innate Signals
Imanishi, T., & Saito, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.01.003 · Cited by 67
Immunotherapy in Ovarian Cancer
Siminiak, N., Czepczyński, R., Zaborowski, M. P., & Iżycki, D. (2022) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-022-00655-8 · Cited by 66
“Antigenpresenting cells (APCs), similarly to dendritic cells, migrate to the lymph nodes and present antigens to T cells, which in turn are responsible for attacking cancer via TCRs (Chen and Flies 2013).”
Background
Advances and applications in single-cell and spatial genomics
Wang, J., Ye, F., Chai, H., Jiang, Y., Wang, T., Ran, X., Xia, Q., Xu, Z., Fu, Y., Zhang, G., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2770-x · Cited by 70
B7H1/CD80 Interaction Augments PD-1–Dependent T Cell Apoptosis and Ameliorates Graft-versus-Host Disease
Deng, R., Cassady, K. M., Li, X., Yao, S., Zhang, M., Racine, J. J., Lin, J. J., Chen, L., & Zeng, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402157 · Cited by 66
Self-citation
Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibody
Xue, L., Hickling, T. P., Song, R., Nowak, J., & Rup, B. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12711 · Cited by 68
Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300
Jeung, Y. S., Kim, H., Ahn, J., Lee, H., Lee, S.-B., Won, M., Jung, C.-R., Im, J., Kim, B., Park, S., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.07.005 · Cited by 65
Dynamic regulation of CD28 conformation and signaling by charged lipids and ions
Yang, W., Pan, W., Chen, S., Trendel, N., Jiang, S., Xiao, F., Xue, M., Wu, W., Peng, Z., Li, X., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3489 · Cited by 66
Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors
Abdin, S. M., Zaher, D. M., Arafa, E. A., & Omar, H. A. (2018) · Cancers · doi:10.3390/cancers10020032 · Cited by 66
Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario
Rossi, G., Pezzuto, A., Sini, C., Tuzi, A., Citarella, F., McCusker, M. G., Nigro, O., Tanda, E. T., & Russo, A. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.07.005 · Cited by 66
Transcriptome profiling of antiviral immune and dietary fatty acid dependent responses of Atlantic salmon macrophage-like cells
Eslamloo, K., Xue, X., Hall, J. R., Smith, N. C. P., Caballero‐Solares, A., Parrish, C. C., Taylor, R. G., & Rise, M. L. (2017) · BMC Genomics · doi:10.1186/s12864-017-4099-2 · Cited by 67
Cellular Signaling Pathways in Medium and Large Vessel Vasculitis
Watanabe, R., Berry, G. J., Liang, D. H., Goronzy, J. J., & Weyand, C. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587089 · Cited by 65
BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
Demerle, C., Gorvel, L., & Olive, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682007 · Cited by 68
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
Labiano, S., Palazón, A., Bolaños, E., Azpilikueta, A., Sánchez-Paulete, A. R., Morales‐Kastresana, A., Quetglas, J. I., Perez‐Gracia, J. L., Gúrpide, A., Rodriguez-Ruiz, M. E., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1062967 · Cited by 68
Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all- trans retinoic acid in acute myeloid leukemia across subtypes
Smitheman, K. N., Severson, T., Rajapurkar, S., McCabe, M. T., Karpinich, N. O., Foley, J. J., Pappalardi, M. B., Hughes, A. M., Halsey, W. S., Thomas, E., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.199190 · Cited by 68
HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors
Kinosada, H., Yasunaga, J., Shimura, K., Miyazato, P., Onishi, C., Iyoda, T., Inaba, K., & Matsuoka, M. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006120 · Cited by 68
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis
Salou, M., Nicol, B., Garcia, A., Baron, D., Michel, L., Elong-Ngono, A., Hulin, P., Nedellec, S., Jacq-Foucher, M., Le Frère, F., et al. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.03.014 · Cited by 70
Immunosuppression after Sepsis: Systemic Inflammation and Sepsis Induce a Loss of Naïve T-Cells but No Enduring Cell-Autonomous Defects in T-Cell Function
Markwart, R., Condotta, S. A., Requardt, R. P., Borken, F., Schubert, K., Weigel, C., Bauer, M. W., Griffith, T. S., Förster, M., Brunkhorst, F. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115094 · Cited by 64
Frontline Science: Anti-PD-L1 protects against infection with common bacterial pathogens after burn injury
Patil, N. K., Luan, L., Bohannon, J. K., Hernandez, A., Guo, Y., & Sherwood, E. R. (2017) · Journal of Leukocyte Biology · doi:10.1002/jlb.5hi0917-360r · Cited by 63
Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite‐Protein Interaction Network
Chen, D., Zhang, Y., Wang, W., Chen, H., Ling, T., Yang, R., Wang, Y., Duan, C., Liu, Y., Guo, X., et al. (2021) · Advanced Science · doi:10.1002/advs.202100311 · Cited by 62
Glycosylation Shapes the Efficacy and Safety of Diverse Protein, Gene and Cell Therapies
Rocamora, F., Peralta, A. G., Shin, S., Sorrentino, J., Wu, M. Y. M., Toth, E. A., Fuerst, T. R., & Lewis, N. E. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108206 · Cited by 67
Biophysical Aspects of T Lymphocyte Activation at the Immune Synapse
Hivroz, C., & Saitakis, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00046 · Cited by 64
Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools
Klarquist, J. S., Zhou, Z., Shen, N., & Janssen, E. M. (2016) · Mediators of Inflammation · doi:10.1155/2016/5045248 · Cited by 64

Authors: Chen, L., & Flies, D. B.
Affiliations: Yale Cancer Center (US)
University of New Mexico (US)
Corresponding author: Chen, Lieping
ORCID: Chen, Lieping
Flies, Dallas B.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2013-03-08
Volume: 13
Issue: 4
Pages: 227-242
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/nri3405
PMC: PMC3786574
OpenAlex: W2130473166
Cited by: 3,114
References: 135
Citations by year: 2026: 148 · 2025: 258 · 2024: 259 · 2023: 276 · 2022: 305 · 2021: 312 · 2020: 310 · 2019: 250 · 2018: 275 · 2017: 238 · 2016: 195 · 2015: 148 · 2014: 101 · 2013: 35
FWCI: 13.52
Type: journal article
Language: en
Update notices: erratum (2013-06-05)
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Melanoma Research Alliance
National Cancer Institute (CA 97085, CA 16359, CA121974, CA86721, R01CA097085, CA142779, R01CA085721, R01CA142779, P50CA121974, P30CA016359)
National Institute of Allergy and Infectious Diseases (T32AI089704, R01AI072592, AI72592, T32AI007247)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: T cell costimulation, T cell co-inhibition, costimulatory receptors, co-inhibitory receptors, T cell receptor signaling, T cell activation, T cell differentiation, immune checkpoint molecules
MeSH terms: Humans, Lymphocyte Activation, Receptors, Antigen, T-Cell, T-Lymphocytes, Signal Transduction, CD28 Antigens, B7-1 Antigen, Models, Immunological, B7-2 Antigen, Receptors, Tumor Necrosis Factor, Member 14

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of T cell co-stimulation and co-inhibition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks